首页> The lancet. HIV> Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study.

Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Elizabeth D,Lowenthal

第一单位： The Children's Hospital of Philadelphia, Division of General Pediatrics and Global Health Center, Philadelphia, PA, USA; University of Pennsylvania Perelman School of Medicine, Departments of Pediatrics and Biostatistics, Epidemiology and Informatics, Philadelphia, PA, USA. Electronic address: lowenthale@chop.edu.

作者： Elizabeth D,Lowenthal ^[1] ; Jennifer,Chapman ^[2] ; Rachel,Ohrenschall ^[3] ; Katherine,Calabrese ^[4] ; Kristin,Baltrusaitis ^[5] ; Barbara,Heckman ^[6] ; Dwight E,Yin ^[7] ; Allison L,Agwu ^[8] ; Conn,Harrington ^[9] ; Rodica M,Van Solingen-Ristea ^[10] ; Cynthia C,McCoig ^[11] ; Adeola,Adeyeye ^[7] ; Jared,Kneebone ^[6] ; Vasiliki,Chounta ^[9] ; Christiana,Smith-Anderson ^[12] ; Andres,Camacho-Gonzalez ^[13] ; Jessica,D'Angelo ^[14] ; Allison,Bearden ^[15] ; Herta,Crauwels ^[10] ; Jenny,Huang ^[9] ; Sarah,Buisson ^[4] ; Ryan,Milligan ^[6] ; Shawn,Ward ^[6] ; Carolyn,Bolton-Moore ^[16] ; Aditya H,Gaur ^[17] ; IMPAACT 2017 Collaborators ; IMPAACT 2017 Team

作者单位： The Children's Hospital of Philadelphia, Division of General Pediatrics and Global Health Center, Philadelphia, PA, USA; University of Pennsylvania Perelman School of Medicine, Departments of Pediatrics and Biostatistics, Epidemiology and Informatics, Philadelphia, PA, USA. Electronic address: lowenthale@chop.edu. ^[1] The Children's Hospital of Philadelphia, Division of General Pediatrics and Global Health Center, Philadelphia, PA, USA. ^[2] University of Pennsylvania School of Nursing, Philadelphia, PA, USA. ^[3] FHI 360 IMPAACT Operations Center, Durham, NC, USA. ^[4] Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, USA. ^[5] Frontier Science Foundation, Amherst, NY, USA. ^[6] National Institute of Allergy and Infectious Diseases (NIAID) Division of AIDS, National Institutes of Health (NIH), Rockville, MD, USA. ^[7] Johns Hopkins University School of Medicine, Baltimore, MD, USA. ^[8] ViiV Healthcare, Research Triangle Park, NC, USA. ^[9] Janssen Research and Development, Beerse, Belgium. ^[10] ViiV Healthcare, Madrid, Spain. ^[11] University of Colorado School of Medicine, Aurora, CO, USA. ^[12] Emory University School of Medicine, Atlanta, GA, USA. ^[13] Northwestern University and Lurie Children's Hospital of Chicago, Chicago, IL, USA. ^[14] Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. ^[15] Centre for Infectious Disease Research in Zambia/University of Alabama Birmingham, Lusaka, Zambia. ^[16] St Jude Children's Research Hospital, Memphis, TN, USA. ^[17]

医学主题词成年人(Adult);儿童(Child);人类(Humans);青少年(Adolescent);抗HIV药(Anti-HIV Agents);HIV感染(HIV Infections);生活质量(Quality of Life);抗逆转录病毒药(Anti-Retroviral Agents);HIV血清阳性(HIV Seropositivity);HIV-1(HIV-1);疼痛(Pain);吡啶酮类(Pyridones);二酮哌嗪类(Diketopiperazines)

DOI 10.1016/S2352-3018(23)00301-6

PMID 38538161

发布时间 2026-03-17

基金项目

U01 AI069463/AI/NIAID NIH HHS/United States UM1 AI068632/AI/NIAID NIH HHS/United States UM1 AI069399/AI/NIAID NIH HHS/United States UM1 AI106716/AI/NIAID NIH HHS/United States HHSN275201800001I/HD/NICHD NIH HHS/United States U01 AI068632/AI/NIAID NIH HHS/United States HHSN275201800001C/HD/NICHD NIH HHS/United States UM1 AI069463/AI/NIAID NIH HHS/United States UM1 AI068616/AI/NIAID NIH HHS/United States

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The lancet. HIV

2024年11卷4期

e222-e232页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

The lancet. HIV

2024年11卷4期

e222-e232页

检索历史清除

Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study.

The lancet. HIV

相似文献

同项目论文

The lancet. HIV

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study.

The lancet. HIV

相似文献

同项目论文

The lancet. HIV

相关期刊

检索历史清除